Envista Holdings NVST
NYSE NVST
$26.42 -0.39 (-1.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Envista Holdings (NVST) Operating Income (2018 - 2026)

Envista Holdings (NVST) posted Operating Income of $80.3 million for Q3 2026, up 28.48% on a QoQ basis from $62.5 million in Q2 2026, and up 73.43% year-over-year from $46.3 million in Q3 2025.

Analysis

Envista Holdings (NVST) Operating Income (2018 - 2026) Analysis & Trends

Envista Holdings has reported Operating Income for 9 years, with the latest figure at $80.3 million in Q3 2026.

  • On a quarterly basis, Operating Income rose 73.43% year-over-year to $80.3 million in Q3 2026; TTM through Jul 2026 was $273.6 million, a 79.65% increase from a year earlier, with the FY2025 full-year figure at $216.1 million, up 120.81% from the prior year.
  • Operating Income was $80.3 million for Q3 2026 at Envista Holdings, up from $62.5 million in the prior quarter.
  • The five-year high for Operating Income was $91.5 million in Q2 2022, with the low at -$1.2 billion in Q2 2024.
  • Average Operating Income over 5 years is -$18.3 million, with a median of $63.8 million recorded in 2022.
  • The sharpest annual moves came in 2024 and 2025: Operating Income plunged 1561.72% in 2024, then jumped 175.12% in 2025.
  • Over 5 years, Operating Income stood at $88.0 million in 2022, then tumbled by 330.45% to -$202.8 million in 2023, then surged by 122.73% to $46.1 million in 2024, then jumped by 59.0% to $73.3 million in 2025, then grew by 9.55% to $80.3 million in 2026.
  • The last three Operating Income figures came in at $80.3 million (Q3 2026), $62.5 million (Q2 2026), and $73.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Align Technology 10.91 Bn 9.81 Bn 757.43 Mn 154.01 Mn
2 Envista Holdings 4.28 Bn 3.15 Bn 407.00 Mn 80.30 Mn
3 Dentsply Sirona 2.13 Bn 1.89 Bn 493.00 Mn 82.00 Mn
4 Milestone Scientific 35.27 Mn 32.66 Mn 1.56 Mn -828,083.00
5 Dror Ortho-Design 9.77 Mn 9.68 Mn - -495,766.00
6 Vivos Therapeutics 2.98 Mn 1.18 Mn 2.95 Mn -4.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 80.30 Mn
Apr 3, 2026 62.50 Mn
Dec 31, 2025 73.30 Mn
Sep 26, 2025 57.50 Mn
Jun 27, 2025 46.30 Mn
Mar 28, 2025 39.00 Mn
Dec 31, 2024 46.10 Mn
Sep 27, 2024 20.90 Mn
Jun 28, 2024 -1.15 Bn
Mar 29, 2024 48.10 Mn
Dec 31, 2023 -202.80 Mn
Sep 29, 2023 83.30 Mn
Jun 30, 2023 78.90 Mn
Mar 31, 2023 72.10 Mn
Dec 31, 2022 88.00 Mn
Sep 30, 2022 74.50 Mn
Jul 1, 2022 65.20 Mn
Apr 1, 2022 91.50 Mn
Dec 31, 2021 46.10 Mn
Oct 1, 2021 81.70 Mn